Delivery Order SPE2DB22D3011-SPE2DB25FQ2FF
Award Date 8/13/25
Potential Completion Date 8/14/25
Potential Value $2.3K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- AmerisourceBergen Drug Corp was awarded a delivery order on September 4, 2025, by the Defense Logistics Agency (DLA) for 60 tablets of Briviact 100 mg, with a contract value of $1,041.97 and an ultimate completion date of September 5, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a tactical pharmaceutical supply fulfillment under DLA's...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $7,100.94 on August 4, 2025, for the supply of Briviact 75 mg tablets (60-count packages) under a firm fixed-price contract with no set-aside designation. The award is supported by the Defense Logistics Agency's Medical Supply Chain, a division of the Department of Defense, with an ultimate completion date of August 5, 2025. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $5,677.12 to AmerisourceBergen Drug Corp for the supply of Briviact 100 mg tablets (60-count units) on August 18, 2025, with an ultimate completion date of August 19, 2025. This competitive, non-set-aside award employs firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026....
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,072.23 for Briviact 100 mg tablets (60-count) with an ultimate completion date of August 4, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and reflects AmerisourceBergen's role as a critical pharmaceutical supplier within the federal medical procurement system. The place of performance is listed as Conshohocken, Pennsylvania, where AmerisourceBergen...
- The Defense Logistics Agency awarded a $3,574.48 delivery order to AmerisourceBergen Drug Corp for 60 tablets of Briviact 100 mg on August 25, 2025, with completion scheduled for August 26, 2025. This non-set-aside contract was awarded on a firm fixed price basis and represents a child delivery order under AmerisourceBergen's larger pharmaceutical supply agreement with DLA. The pharmaceutical product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This...
- AmerisourceBergen Drug Corp has been awarded a delivery order valued at $18,965.18 for 60-tablet packages of Briviact 25 mg, a pharmaceutical product, under a Firm Fixed Price contract with the Defense Logistics Agency Medical Supply Chain. The award was issued on August 27, 2025, with an ultimate completion date of August 28, 2025, and represents a non-set-aside competitive award. Performance will be executed at the company's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Briviact 75 mg tablets (60-count units) with a ceiling value of $3,651.35. This firm fixed-price delivery order, which is expected to be completed by August 5, 2025, will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation, reflecting the contractor's demonstrated...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 6, 2025, for Briviact 75 mg tablets (60-count supply) under a firm fixed-price contract with a ceiling value of $1,341.06. This is a non-set-aside, competitively awarded delivery order with a completion date of August 7, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement,...
- The Defense Logistics Agency awarded a delivery order valued at $2,786.07 to AmerisourceBergen Drug Corp for Briviact 100 mg tablets (60-count) on June 11, 2025, with an ultimate completion date of June 12, 2025. This firm fixed-price, competitively awarded delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The place of performance is...
- The U.S. Department of Defense Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Briviact 25 mg tablets in a quantity of 60 units. This firm fixed-price delivery order, valued at $37,428.48, is scheduled for completion by September 29, 2025, and represents a competitively awarded contract with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the place of performance and is a...